PTM Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$605K Buy
506
+1
+0.2% +$1.02K 0.27% 29
2026
Q1
$468K Buy
505
+1
+0.2% +$1.01K 0.25% 30
2025
Q4
$525K Hold
504
0.3% 26
2025
Q3
$426K Sell
504
-20
-4% -$14.9K 0.25% 32
2025
Q2
$409K Buy
524
+50
+11% +$38.9K 0.27% 28
2025
Q1
$344K Buy
+474
New +$394K 0.36% 28

Other funds holding LLY

PTM Wealth Management's LLY Position: Q2 2026 in Review

PTM Wealth Management increased its Eli Lilly (LLY) stake by 0.2% in Q2 2026, buying an estimated $1.02K and bringing the position to 506 shares worth $605K. The position accounts for 0.27% of the portfolio, ranked #29.

PTM Wealth Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • PTM Wealth Management held 506 shares of Eli Lilly worth $605K as of Q2 2026.
  • PTM Wealth Management bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.27% of PTM Wealth Management's portfolio in Q2 2026, its #29 holding.
  • PTM Wealth Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PTM Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.